GL1X · GenesisL1 explorer

MolNFT v1 · #140019 · protein

Crystal structure of SMYD3 in complex with covalent inhibitor 1

5XXD · SMYD3 methyltransferase: “Crystal structure of SMYD3 in complex with covalent inhibitor 1”. X-ray diffraction, 3 ligands (SAM, 8NR, ZN), 4 pockets (best druggability 0.79). MolNFT v1 #140019 on GenesisL1: 3D structure, binding sites…

PDB
5XXD
Type
protein
Length
423 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SMYD3 methyltransferase
Ligands
SAM, 8NR, ZN
Pockets
4 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASMYD3 methyltransferaseprotein42349% helix, 13% strand—

Ligands and binding sites

  • SAM · S-adenosylmethionine · ligand · chains A
  • 8NR · Ethyl 4-(5,6,7,8-tetrahydroacridin-3-ylcarbonyl) piperazine-1-carboxylate · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110570.790.81101SAM, 8NR
22010.530.7831empty
3940.420.7823empty
4500.310.7713empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5XXD · Crystal structure of SmyD3 in complex with covalent inhibitor 1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.